11941486|t|Genetic variation in alpha(1)-antichymotrypsin and its association with Alzheimer's disease.
11941486|a|Alzheimer's disease (AD) is a devastating neurodegenerative disorder characterized by extracellular neuritic plaques and intracellular neurofibrillary tangles in brain parenchyma. Alpha-1-antichymotrypsin (ACT) is a component of plaque cores, can bind to Abeta, and has been proposed as a possible candidate gene for AD susceptibility. The genetic association between the ACT codon -17*A allele of the signal peptide polymorphism and AD has been shown in some, but not in all studies. One hypothesis is that the ACT codon -17*A allele is in linkage disequilibrium with unknown functional mutation(s) in the ACT gene. This study was undertaken to identify new mutation(s) in the ACT gene by PCR-SSCP-sequencing and, in conjunction with known mutations, to assess their role in affecting the risk of AD. A total of seven new point mutations were observed: 5'UTR(A-->G), Asp128Asn(G-->A), Ser250Ser(C-->T), Leu301Pro(T-->C), Thr324Thr(A-->G), G-->A in intron 4, and 3'UTR C-->A. Of these, mutations at codon 250, codon 324, intron 4 and 3'UTR showed a frequency of 1% or more. Of the known mutations, Thr-17Ala(A-->G), Lys76Lys(A-->G) and Leu241Leu(G-->A) occur at a polymorphic level. The ACT codon -17*A allele was associated with increased risk of AD (OR for AA vs TT: 1.71; 95% CI: 1.16-2.53; P=0.007), especially in the presence of the APOE*4 allele (OR for AA vs TT: 2.35; 95% CI: 1.13-4.85; P=0.02). The codon 241*A allele and the codon 250*T allele were associated with protective effects against AD (OR: 0.36; 95% CI: 0.13-0.86; P=0.02) (OR:0.39; 95% CI: 0.18-0.85; P=0.02). irrespective of the APOE*4 status. The codon 324*G allele was associated with a marginal protective effect (OR:0.57; 95% CI: 0.26-1.26; P=0.17). While the codon 241*A allele was in linkage disequilibrium with the codon -17*A allele, the codon 250*T and codon 324*G alleles were non-randomly associated with the codon -17*T allele. In contrast, the codon 76*G (OR:1.34; 95% CI: 0.92-1.95; P=0.13), codon 227*G (OR:3.96; 95% CI: 0.83-18.8; P=0.08) and intron 4*G (OR:1.47; 95% CI: 0.88-2.29; P=0.15) alleles were associated with a modest risk of AD, and all were in linkage disequilibrium with the codon -17*A allele. EH-based haplotype analysis showed that certain haplotypes are associated with either higher or lower risk of AD. Our data indicate that the ACT gene harbors several potentially important variable sites, which are associated with either an increased or decreased risk of AD. The non-random combination of risk and protective alleles may explain, in part, why the association studies regarding the ACT codon -17*A have been inconsistent, especially if the frequency of other ACT mutations varies between populations.
11941486	21	46	alpha(1)-antichymotrypsin	Gene	12
11941486	72	91	Alzheimer's disease	Disease	MESH:D000544
11941486	93	112	Alzheimer's disease	Disease	MESH:D000544
11941486	114	116	AD	Disease	MESH:D000544
11941486	135	161	neurodegenerative disorder	Disease	MESH:D019636
11941486	193	209	neuritic plaques	Disease	MESH:D058225
11941486	228	251	neurofibrillary tangles	Disease	MESH:D055956
11941486	273	297	Alpha-1-antichymotrypsin	Gene	12
11941486	299	302	ACT	Gene	12
11941486	348	353	Abeta	Gene	351
11941486	410	412	AD	Disease	MESH:D000544
11941486	465	468	ACT	Gene	12
11941486	527	529	AD	Disease	MESH:D000544
11941486	605	608	ACT	Gene	12
11941486	700	703	ACT	Gene	12
11941486	771	774	ACT	Gene	12
11941486	891	893	AD	Disease	MESH:D000544
11941486	953	958	A-->G	DNAMutation	tmVar:c|SUB|A||G;VariantGroup:10;CorrespondingGene:12;CorrespondingSpecies:9606
11941486	961	970	Asp128Asn	ProteinMutation	tmVar:p|SUB|D|128|N;HGVS:p.D128N;VariantGroup:0;CorrespondingGene:348;RS#:763313394;CorrespondingSpecies:9606;CA#:9506052
11941486	971	976	G-->A	DNAMutation	tmVar:c|SUB|G||A;VariantGroup:11;CorrespondingGene:12;CorrespondingSpecies:9606
11941486	979	988	Ser250Ser	ProteinMutation	tmVar:p|SUB|S|250|S;HGVS:p.S250S;VariantGroup:4;CorrespondingGene:12;CorrespondingSpecies:9606
11941486	989	994	C-->T	DNAMutation	tmVar:c|SUB|C||T;VariantGroup:12;CorrespondingGene:12;CorrespondingSpecies:9606
11941486	997	1006	Leu301Pro	ProteinMutation	tmVar:p|SUB|L|301|P;HGVS:p.L301P;VariantGroup:6;CorrespondingGene:12;CorrespondingSpecies:9606
11941486	1007	1012	T-->C	DNAMutation	tmVar:c|SUB|T||C;VariantGroup:3;CorrespondingGene:12;CorrespondingSpecies:9606
11941486	1015	1024	Thr324Thr	ProteinMutation	tmVar:p|SUB|T|324|T;HGVS:p.T324T;VariantGroup:7;CorrespondingGene:12;CorrespondingSpecies:9606
11941486	1025	1030	A-->G	DNAMutation	tmVar:c|SUB|A||G;VariantGroup:10;CorrespondingGene:12;CorrespondingSpecies:9606
11941486	1033	1050	G-->A in intron 4	DNAMutation	tmVar:c|SUB|G|4|A;HGVS:c.4G>A;VariantGroup:1;CorrespondingGene:12;RS#:764398968;CorrespondingSpecies:9606
11941486	1062	1067	C-->A	DNAMutation	tmVar:c|SUB|C||A;VariantGroup:8;CorrespondingGene:12;CorrespondingSpecies:9606
11941486	1191	1200	Thr-17Ala	ProteinMutation	tmVar:p|SUB|T|17|A;HGVS:p.T17A;VariantGroup:2;CorrespondingGene:351;RS#:762505107;CorrespondingSpecies:9606;CA#:9987776
11941486	1201	1206	A-->G	DNAMutation	tmVar:c|SUB|A||G;VariantGroup:10;CorrespondingGene:12;CorrespondingSpecies:9606
11941486	1209	1217	Lys76Lys	ProteinMutation	tmVar:p|SUB|K|76|K;HGVS:p.K76K;VariantGroup:9;CorrespondingGene:12;CorrespondingSpecies:9606
11941486	1218	1223	A-->G	DNAMutation	tmVar:c|SUB|A||G;VariantGroup:10;CorrespondingGene:12;CorrespondingSpecies:9606
11941486	1229	1238	Leu241Leu	ProteinMutation	tmVar:p|SUB|L|241|L;HGVS:p.L241L;VariantGroup:5;CorrespondingGene:12;CorrespondingSpecies:9606
11941486	1239	1244	G-->A	DNAMutation	tmVar:c|SUB|G||A;VariantGroup:11;CorrespondingGene:12;CorrespondingSpecies:9606
11941486	1280	1283	ACT	Gene	12
11941486	1341	1343	AD	Disease	MESH:D000544
11941486	1431	1437	APOE*4	Gene	348
11941486	1595	1597	AD	Disease	MESH:D000544
11941486	1694	1700	APOE*4	Gene	348
11941486	2218	2220	AD	Disease	MESH:D000544
11941486	2400	2402	AD	Disease	MESH:D000544
11941486	2431	2434	ACT	Gene	12
11941486	2561	2563	AD	Disease	MESH:D000544
11941486	2687	2690	ACT	Gene	12
11941486	2764	2767	ACT	Gene	12
11941486	Positive_Correlation	MESH:D000544	HGVS:p.T324T;CorrespondingGene:12
11941486	Positive_Correlation	MESH:D000544	HGVS:p.L241L;CorrespondingGene:12
11941486	Positive_Correlation	RS#:764398968;HGVS:c.4G>A;CorrespondingGene:12	MESH:D000544
11941486	Positive_Correlation	MESH:D000544	RS#:762505107;HGVS:p.T17A;CorrespondingGene:351
11941486	Positive_Correlation	MESH:D000544	348
11941486	Positive_Correlation	MESH:D000544	HGVS:p.S250S;CorrespondingGene:12
11941486	Positive_Correlation	CorrespondingGene:12;CorrespondingSpecies:9606;VariantGroup:11;tmVar:c	MESH:D000544
11941486	Positive_Correlation	MESH:D000544	RS#:763313394;HGVS:p.D128N;CorrespondingGene:348
11941486	Positive_Correlation	MESH:D000544	HGVS:p.K76K;CorrespondingGene:12
11941486	Positive_Correlation	MESH:D000544	HGVS:p.L301P;CorrespondingGene:12
11941486	Association	12	348
11941486	Positive_Correlation	CorrespondingGene:12;CorrespondingSpecies:9606;VariantGroup:10;tmVar:c	MESH:D000544
11941486	Association	12	351
11941486	Association	MESH:D000544	12
11941486	Association	MESH:D000544	12
11941486	Association	MESH:D000544	351
11941486	Association	MESH:D000544	348

